Composition for delivering physiologically active ingredients into blood vessel

A bioactive substance and composition technology, applied in the direction of organic active ingredients, medical preparations containing active ingredients, genetic material components, etc., can solve problems such as undeveloped delivery systems, achieve excellent embolism effects, and reduce side effects

Active Publication Date: 2020-05-08
LEMONEX
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, a universally applicable delivery system capable of delivering a wide variety of bioactive materials, a system capable of containing and delivering large quantities of drugs, and a system for releasing drugs in a sustained manner has not yet been developed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for delivering physiologically active ingredients into blood vessel
  • Composition for delivering physiologically active ingredients into blood vessel
  • Composition for delivering physiologically active ingredients into blood vessel

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0241] The preparation and pore expansion of the small-pore particles can be performed according to the above-mentioned procedures, and then the washing and drying procedures can be performed.

[0242] If necessary, unreacted material can be separated by separating the supernatant, eg, by centrifugation, prior to washing.

[0243] The centrifugation may be performed at, for example, 6,000 to 10,000 rpm for, for example, 3 to 60 minutes, specifically, 3 to 30 minutes, 5 to 30 minutes, etc. within the above range, but is not limited thereto.

[0244] Washing after preparing the small-pore particles may be performed in any method under the conditions within the above range, but is not limited thereto.

[0245] Washing after pore expansion can be performed under more relaxed conditions than in the illustrative embodiments described above. For example, washing may be performed three times or less, but is not limited thereto.

[0246] The surface of the particles and / or the inside...

Embodiment 1

[0280] Example 1 - Preparation of Porous Silica Particles

[0281] (1) Preparation of Particle 1

[0282] 1) Preparation of Small Pore Particles

[0283] 960ml of distilled water (DW) and 810ml of MeOH were placed in a 2L round bottom flask. 7.88 g of CTAB was added to the flask, followed by the rapid addition of 4.52 ml of 1M NaOH while stirring. After introducing the homogeneous mixture under stirring for 10 minutes, 2.6 ml of TMOS were added thereto. After stirring for 6 hours for uniform mixing, the mixture was aged for 24 hours.

[0284] Then, the reaction solution was centrifuged at 25° C. and 8000 rpm for 10 minutes to remove the supernatant. During centrifugation at 25° C. and 8000 rpm for 10 minutes, the product was washed five times alternately with ethanol and distilled water.

[0285] Thereafter, the resultant was dried in an oven at 70° C. to obtain 1.5 g of powdery small-pore porous silica particles (average pore diameter: 2 nm, particle diameter: 200 nm)....

Embodiment 2

[0327] Example 2 - Surface modification of porous silica particles

[0328] (1) positive charge

[0329] 1) Amino-particles with a particle size of 300nm

[0330] The porous silica particles in Example 1-(4) were reacted with (3-aminopropyl)triethoxysilane (APTES) to be positively charged.

[0331] Specifically, 100 mg of porous silica particles were dispersed in 10 ml of toluene in a 100 ml round bottom flask by means of a bath sonicator. Then, 1 ml of APTES was added and stirred at 130° C. and 400 rpm for 12 hours.

[0332] After the reaction, the product was slowly cooled to room temperature, and then centrifuged at 8000 rpm for 10 minutes to remove the supernatant. During centrifugation at 25° C. and 8000 rpm for 10 minutes, the product was washed five times alternately with ethanol and distilled water.

[0333] Then, the washed product was dried in an oven at 70° C. to obtain powdery porous silica particles having amino groups on the surface of the particles and ins...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to view more

Abstract

A composition comprising porous silica particles of the present invention has a modified surface which inhibits clotting and precipitation in blood, thereby effectively delivering physiologically active ingredients to target tissue or cells in the bloodstream. Also, in addition to the above advantage, a composition for an embolization procedure comprising porous silica particles of the present invention has the advantages of having biodegradability and sustained release properties such that excellent embolization effects may be obtained, and having excellent targeting properties for tumor tissue or cells and thereby causes few side effects.

Description

technical field [0001] The present invention relates to compositions for the delivery of physiologically active ingredients to blood vessels Background technique [0002] Drug delivery system refers to the medical technology that minimizes the side effects of conventional drugs and maximizes the potency and effect to effectively deliver the required amount of drugs, such as proteins, nucleic acids or other small molecules. Recently, this technology that reduces the cost and time required to develop new drugs is combined with nanotechnology to become one of the cutting-edge technologies that create new added value in the medical world. In the late 1980s, countries with advanced technology, such as the United States, Japan, etc., were concentrating on the development of drug delivery systems and the development of new drugs around enterprises such as pharmaceutical companies. [0003] So far, viral genes, recombinant proteins, liposomes, cationic polymers, and nanoparticles a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61K45/06A61L24/00A61L24/02A61K9/14A61K48/00A61K31/704A61K49/00
CPCA61K9/0019A61K9/143A61K9/1611A61K9/5115A61K45/00A61P9/00A61P9/12A61P3/06A61P9/10A61P9/14A61K31/704A61K45/06A61K48/00A61L24/02A61K31/44A61K38/465A61K31/203A61K31/4745A61K38/1709C12Y301/27005A61K38/385C12N15/1136C12N15/111C12N2310/14C12N2320/32A61K47/44A61L2400/12A61L24/0015A61L24/0036A61L2400/18A61K49/0093A61L2430/36A61K49/04A61L24/001C07K16/2818C07K16/2827
Inventor 元哲喜
Owner LEMONEX
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap